Aura Biosciences, Inc. Other Noncash Income (Expense)
Aura Biosciences, Inc. (AURA) reported Other Noncash Income (Expense) of $9.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Cash Flow
us-gaap:OtherNoncashIncomeExpense · last filed 2022-05-12
- Aura Biosciences, Inc. other noncash income (expense) for the quarter ending 2022-03-31 was $9.00K, a 125.00% increase year-over-year.
- Aura Biosciences, Inc. other noncash income (expense) for the quarter ending 2021-03-31 was $4.00K.
| Period end | Other Noncash Income (Expense) 3 month |
|---|---|
| 2022-03-31 | $9.00K 10-Q · filed 2022-05-12 |
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |